⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLNN News
Clene Inc. Common Stock
Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®
globenewswire.com
CLNN
Clene to Provide CNM-Au8® ALS Program Update
globenewswire.com
CLNN
Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference
globenewswire.com
CLNN
Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights
globenewswire.com
CLNN
Clene to Participate in a Panel Discussion at the Maxim Growth Summit
globenewswire.com
CLNN
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients
globenewswire.com
CLNN